Calypso Sequencing Ltd
CALYPSO™ is a revolutionary sequencing platform that offers a fully automated solution for nucleic acid extraction and library preparation, streamlining your old NGS workflow and eliminating the timeconsuming and error-prone manual steps often associated with traditional methods. This innovative platform efficiently processes a wide variety of raw samples, including both DNA and RNA, generating high-quality, sequence-ready libraries within a remarkable timeframe of under 2 hours. Pre-loaded onboard reagents and our proprietary system works in tandem to minimize sample loss and ensure consistent processing across experiments. By empowering researchers with a robust platform for streamlined NGS workflows, CALYPSO™ accelerates discovery and maximizes research output.
Industries
N/A
Awards
Funding Opportunity: 25-10-DTRA_Multi “Advancing Biodefense Readiness: On-Demand Biologics, Automated Threat Detection, and Alternative for Testing Medical Countermeasures in High Containment”
Automated In-Field Sequencing Preparation, Sequencing and Data Analytics Solution for Complex Samples (Leviathan)
Funding (ceiling)
$2,618,773.7
Award Year
2026